Verona Pharma plc (VRNA) has 33 open-market insider trades by 18 insiders since 2022. The most active filer is David R. Ebsworth, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Rishi Gupta | Dir | — | 2 | $212.4M | 2023-05-15 |
| OrbiMed Capital GP VI LLC | Dir | — | 1 | $64.7M | 2022-12-23 |
| Len Blavatnik | 10% Owner | — | 1 | $6.3M | 2022-08-15 |
| David Zaccardelli | CEOPres | — | 4 | $3.5M | 2025-10-07 |
| Mark W. Hahn | CFO | — | 3 | $3.4M | 2025-10-07 |
| Orbimed Advisors LLC | Dir | — | 1 | $1.8M | 2023-05-11 |
| Claire Poll | CLO | — | 2 | $1.0M | 2024-02-01 |
| David R. Ebsworth | Dir | — | 5 | $812K | 2025-10-07 |
| Andrew Fisher | CLO | — | 2 | $720K | 2025-10-07 |
| Christina Ackermann | Dir | — | 2 | $421K | 2025-10-07 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David Zaccardelli | CEO & President | Sell | $5.5M | 2025-08-01 |
| Vikas Sinha | Director | Sell | $114K | 2025-08-01 |
| Andrew Fisher | CLO | Sell | $252K | 2025-08-01 |
| David R. Ebsworth | Director | Sell | $25K | 2025-08-01 |
| Kathleen A. Rickard | — | Sell | $1.5M | 2025-08-01 |
| Mahendra Shah | Director | Sell | $47K | 2025-08-01 |
Companies that share insiders with VRNA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Kenneth Cunningham | Director | Sell | $284K | 2025-08-01 |
| Lisa Deschamps | Director | Sell | $249K | 2025-08-01 |
| James Aloysius Brady | Director | Sell | $11K | 2025-08-01 |
| Christina Ackermann | Director | Sell | $24K | 2025-08-01 |
| Michael Austwick | Director | Sell | $297K | 2025-08-01 |
| Andrew Fisher | CLO | Sell | $922K | 2025-06-16 |
| Mark W. Hahn | CFO | Sell | $4.6M | 2025-06-11 |
| David Zaccardelli | CEO & President | Sell | $7.1M | 2025-05-27 |
| Mark W. Hahn | CFO | Sell | $7.5M | 2025-05-27 |